BM, BCH, MA, MRCGP, DPhil
Professor of Evidence-Based Medicine
- Director of CEBM & Programs in EBHC
- Editor in Chief, BMJ EBM
- NHS Urgent Care GP
- NIHR Senior Investigator
Carl Heneghan is a clinical epidemiologist with expertise in evidence-based medicine, research methods, and evidence synthesis.
He is Director of the NIHR SPCR Evidence Synthesis Working Group a collaboration of nine primary care departments across UK universities. He has published 95 systematic reviews, and authored high impact work including systematic reviews on the antivirals Tamiflu. He set up and directs the Oxford COVID Evidence Service and has expertise in analysing epidemiological data and interpreting the biases. He is Editor of the Catalogue of Bias.
His work also includes investigating drugs and devices, advising governments on regulatory evidence and working with the media assessing health claims.
He has investigated the evidence for sports drinks, IVF 'add-on' treatments, metal-hips, cancer screening, health-checks, surgical mesh, medical devices and hormone pregnancy tests. He has worked in diagnosis and is a lead for the Preventing Overdiagnosis Conference.
He is a clinical advisor to two UK All Parliamentary Party Group on Surgical Mesh and Hormone Pregnancy Tests, and A founder of the AllTrials campaign twice voted one of the top 100 NHS clinical leaders by the HSJ. In 2018 he was awarded NIHR Senior Investigator status
In 2019 he received a lifetime achievement award from Oxford's Medical Science Division for his sustained commitment to education and teaching.
He is Director of the Centre for Evidence-Based Medicine (CEBM), which builds capacity through teaching and training activities. He teaches undergraduates, postgraduates and teachers of EBM, and is Director of Programs in Evidence-Based Health Care,
Dissemination and Media: See find an expert page
The BMJ Talk Evidence podcast: Duncan Jarvies, Helen Macdonald and Carl Heneghan – with occasional guests- discuss what’s been happening in the world of evidence. He is Editor in Chief of BMJ Evidence-Based Medicine and
He has over 400 peer-reviewed publications (current H Index 64) and co-authored the EBM toolkit and Statistics Toolkit (BMJ-Blackwell’s) and, developed the EvidenceLive conference, now in its 10th year.
Conflicts of interest and payments:
Carl has received expenses and fees for his media work (including payments from BBC Radio 4 Inside Health). He has received expenses from the WHO, FDA, and holds grant funding from the NIHR, the NIHR School of Primary Care Research, The NIHR BRC Oxford and the WHO. He has received financial remuneration from an asbestos case and to date has given legal advice on mesh cases. He has also received income from the publication of a series of toolkit books published by Blackwells. On occasion, he receives expenses for teaching EBM and is also paid for his GP work in NHS out of hours (contract with Oxford Health NHS Foundation Trust). He is Director of CEBM, which jointly runs the EvidenceLive Conference with the BMJ and the Overdiagnosis Conference with international partners, based on a non-profit making model. He is Editor in Chief of BMJ Evidence-Based Medicine and is an NIHR Senior Investigator.
(2018), BMJ evidence-based medicine, 23, 1 - 3
Nunan D. et al, (2017), Evidence-Based Medicine, 22, 202 - 204
Hayward GN. et al, (2017), JAMA - Journal of the American Medical Association, 317, 1535 - 1543
de Cassan S. et al, (2020), Cochrane Database of Systematic Reviews, 2020
Fitzmaurice D. et al, (2020), Programme Grants for Applied Research, 8, 1 - 104
Richards GC. et al, (2020), BMC Medicine, 18